Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
Timing rebalance decisions for SP 500 retirement funds helps keep your portfolio aligned with goals. This intro covers practical triggers.
16,462 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
When a large investment firm trims a position, it sends a signal to the market. This article explains what timucuan a...
Two popular short-term bond ETFs—VCSH and ISTB—offer different paths to steady income. This guide breaks down cost, r...
Investors are watching silver surge with remarkable momentum. This guide shows how the silver 160% year here trend ha...
On June 10, key inflation data could steer the stock market. This guide explains the scenarios, risk signals, and pra...
A new PWBM study places the insolvency deadline for Social Security's trust fund at 2032, six years from now. It eval...
A growing number of households report gaps in paid time off and career momentum that ripple into investing and retire...
A $3 million retirement portfolio at 70 yields about $69k in real annual spending after taxes and health costs, chall...
The latest Social Security Trustees report shows social security took $1.45 in revenue in 2025, but outlays exceeded ...
The 2026 Trustees report flags a widening funding gap for Social Security, suggesting possible benefit cuts if Congre...
A rising chorus of planners argues the fixed 4% rule may trap retirees in unnecessary caution. Experts say flexible w...
An in-depth look at how much SCHD would be required to replace Social Security income, with current yields, market co...